Hikma Pharmaceuticals PLC
General ticker "HKMPF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $5.7B (TTM average)
Hikma Pharmaceuticals PLC does not follow the US Stock Market performance with the rate: -31.4%.
Estimated limits based on current volatility of 0.9%: low 20.57$, high 20.98$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2025-08-15, amount 0.36$ (Y3.52%)
Short-term HKMPF quotes
Long-term HKMPF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2,517.00MM | $2,875.00MM | $3,127.00MM |
| Operating Expenses | $2,235.00MM | $2,508.00MM | $2,515.00MM |
| Operating Income | $282.00MM | $367.00MM | $612.00MM |
| Non-Operating Income | $-49.00MM | $-86.00MM | $-157.00MM |
| Interest Expense | $68.73MM | $89.10MM | $75.00MM |
| R&D Expense | $144.00MM | $149.00MM | $141.00MM |
| Income(Loss) | $233.00MM | $281.00MM | $455.00MM |
| Taxes | $42.00MM | $89.00MM | $93.00MM |
| Profit(Loss)* | $188.00MM | $190.00MM | $359.00MM |
| Stockholders Equity | $2,135.00MM | $2,198.00MM | $2,310.00MM |
| Inventory | $776.00MM | $891.00MM | $986.00MM |
| Assets | $4,471.00MM | $4,680.00MM | $5,133.00MM |
| Operating Cash Flow | $530.00MM | $608.00MM | $564.00MM |
| Capital expenditure | $138.00MM | $169.00MM | $165.00MM |
| Investing Cash Flow | $-607.00MM | $-333.00MM | $-381.00MM |
| Financing Cash Flow | $-58.00MM | $-337.00MM | $-188.00MM |
| Earnings Per Share** | $0.84 | $0.85 | $1.62 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.